glp-1 bowel obstruction Adverse effects of class drugs. Gastrointestinal issues are Food-induced small bowel obstruction observed
Description
These are dramatic results, consistent with other GLP-1 findings
1 OT2 OD026548
En general, el grado de satisfaccin con el tratamiento fue relativamente alto entre los pacientes analizados
10.1016/s0140-6736(87)91194-9 37 LanghansW
Treatment with the DPP-4 inhibitors, linagliptin (5 mg/kg/day) and sitagliptin (50 mg/kg/day), and the GLP-1 analogue, liraglutide (200 g/kg/day), significantly reduced inflammatory markers such as inducible NO synthase, cyclooxygenase, and VCAM-1 via the AMPK pathway in LPS-induced endotoxemic shock in rats as a model of human sepsis [115]
Benjamin S, Masai E, Kamimura N, Takahashi K, Anderson RC, Faisal PA
